Xenon Pharmaceuticals Inc (NASDAQ:XENE)
| 36.94 Delayed Data As of Oct 04 |  +0.92 / +2.55%Today’s Change | 23.26 Today|||52-Week Range 41.39 | +18.25% Year-to-Date |
Latest XENE News | Press Releases
No recent news for Xenon Pharmaceuticals Inc.
Today’s Trading
| Previous close | 36.04 |
| Today’s open | 36.75 |
| Day’s range | 36.66 - 38.41 |
| Volume | 393,855 |
| Average volume (3 months) | 482,035 |
| Market cap | $2.2B |
Data as of 4:00pm ET, 10/04/2022
Growth & Valuation
| Earnings growth (last year) | -117.87% |
| Earnings growth (this year) | -12.69% |
| Earnings growth (next 5 years) | -10.45% |
| Revenue growth (last year) | -42.68% |
| P/E ratio | NM |
| Price/Sales | 73.92 |
| Price/Book | 3.43 |
Competitors
Data as of 4:00pm ET, 10/04/2022
Financials
| Next reporting date | November 8, 2022 |
| EPS forecast (this quarter) | -$0.51 |
| Annual revenue (last year) | $18.4M |
| Annual profit (last year) | -$78.9M |
| Net profit margin | -427.85% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Burnaby, British Columbia |
Forecasts
